Supranuclear eye movement dysfunction in mitochondrial myopathy with tRNA(LEU) mutation

Area of Science:

• Neurology
• Genetics
• Ophthalmology

Background:

• Mitochondrial myopathies are a group of genetic disorders affecting muscle energy production.
• The tRNA(LEU) mutation at nucleotide 3243 is a common cause of mitochondrial myopathy, often associated with neurological deficits.
• Ophthalmoparesis, or impaired eye movement, is a frequent but poorly understood symptom in these conditions.

Observation:

• A patient with biopsy-proven mitochondrial myopathy and the specific tRNA(LEU) 3243 mutation presented with restricted voluntary eye movements.
• Detailed eye movement recordings showed reduced saccadic velocities, impaired smooth pursuit gain, and abnormal vestibulo-ocular reflex in the affected patient.
• His clinically asymptomatic brother, carrying the same mutation, exhibited subtle, direction-specific saccadic abnormalities but normal smooth pursuit and vestibulo-ocular reflexes.

Findings:

• The affected patient displayed significant deficits in saccadic velocity, smooth pursuit, and vestibulo-ocular reflex function.
• Subtle saccadic abnormalities were detected even in the asymptomatic sibling, suggesting early or subclinical neurophysiological changes.
• These findings highlight a spectrum of eye movement dysfunction associated with the mitochondrial tRNA(LEU) 3243 mutation.

Implications:

• The study suggests that supranuclear dysfunction is a key mechanism contributing to ophthalmoparesis in mitochondrial myopathies.
• Eye movement analysis can serve as a sensitive tool for detecting neurological involvement in mitochondrial diseases, even in asymptomatic individuals.
• Understanding these mechanisms may lead to improved diagnostic approaches and targeted therapies for mitochondrial myopathies.